INOVIQ, a biotechnology company, has announced enhancements to its corporate governance and compliance practices. The company has established an audit committee and implemented a comprehensive code of conduct to ensure ethical and responsible business practices.
Material actions and disclosures
The company has disclosed its commitment to having an independent chairman and a program for inducting new directors. It has also outlined its code of conduct, which requires all business affairs to be conducted legally, ethically, and with integrity. Additionally, INOVIQ has a whistleblower policy and an anti-bribery and corruption policy, both available on its website.
The company’s audit committee, made up of three independent non-executive directors, is responsible for overseeing financial reporting and risk management. The committee’s charter and meeting details are available on the company’s website.
INOVIQ also ensures that its board reviews its performance annually to maintain effective governance and risk management.
These actions reflect INOVIQ’s commitment to maintaining high standards of corporate governance and compliance.